securing investor confidence in a Federal Reserve rate cut this September. Tim Murray, T. Rowe Price Capital Markets strategist of the Multi-Asset division joins Market Domination Overtime to share his outlook on market trends and future Fed actions.
Do you feel like the market cares a little bit more about labor market data right now than inflation data? But think what you can say is the market, you look at the futures market, the fed funds futures market, it's pricing in about 100 basis points of cuts over the balance of the year. If you think about the three meetings, you know, November, you're going to have the election and they're not going to want to do a big, big move there in December is probably a little too long to wait.If we get maybe three cuts or maybe it's even two cuts, I mean, you could sort of argue that that might happen because labor market data is coming in better than we thought.
Innovative Drug Development Drives Growth Amid Rising Rheumatoid Arthritis CasesWilmington, Delaware, United States, Transparency Market Research, Inc.-, Aug. 14, 2024 -- As per the report published by Transparency Market Research, the global rheumatology therapeutics market was worth US$ 48.8 Billion in 2023 and is expected to reach US$ 65.1 Billion by the year 2034 at a CAGR of 2.6 % between 2024 and 2034. Rheumatology therapeutics refers to the branch of medicine tDOVER, Del. — Lt. Gov.
United States United States Latest News, United States United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: YahooFinanceCA - 🏆 47. / 63 Read more »
Source: YahooFinanceCA - 🏆 47. / 63 Read more »